News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Coherent launched PhotonLink, an integrated optics platform for AI datacenters, and expects revenue ramp beginning Q4 2026.
  • Anaptys reported Q2 strength with Jemperli net sales up 34% to $644 million, boosting revenue and net income.
  • The FDA set a PDUFA action date of February 2027 for Jemperli in rectal cancer.
  • newcleo closed a $247 million SPAC business combination and will begin trading on Nasdaq as NWCL on September 22, 2026.
  • Abivax raised €767.1 million in a US offering, completed a royalty buy-back, and extended cash runway into Q4 2029.
  • Gauzy received a Nasdaq delisting notice for sub-$1 share price and missed filings and said it will appeal.

Latest Articles

iPower Signs Non-Binding LOI for Proposed $6 Million GPU Deployment

iPower Signs Non-Binding LOI for Proposed $6 Million GPU Deployment

iPower Inc. announced signing a non-binding letter of intent with a prospective customer to lease high-performance GPU systems valued at approximately $6 million, with an anticipated 36-month lease term. The deal marks a significant step in iPower's AI hardware leasing strategy, with potential expansion up to $60 million in total contract value fol…

OKYO Pharma Announces Purchase of Shares by Director

OKYO Pharma Announces Purchase of Shares by Director

OKYO Pharma Limited announced that Non-Executive Director John Brancaccio purchased 5,000 ordinary shares on NASDAQ, raising his total holdings to 35,201 shares. This insider buying comes as the company prepares to initiate a global Phase 3 pivotal clinical trial for urcosimod, targeting neuropathic corneal pain (NCP).

GOOGL slips after blowout quarter as investors balk at a capex surge

GOOGL slips after blowout quarter as investors balk at a capex surge

Alphabet reported a standout Q2 2026 result — $9.11 in EPS versus a $2.88 estimate and $119.80 billion in revenue — yet its Class A shares fell sharply intraday. The market reaction reflects investor unease over an added $15 billion in capital expenditures and related execution and regulatory risks, despite a sizable cloud backlog and other fundame…

Buy CME Into Volatility - Defensive Growth with a High Yield Cushion

Buy CME Into Volatility - Defensive Growth with a High Yield Cushion

CME Group is a cash-generative derivatives exchange with low leverage, a healthy free cash flow stream and a high visible dividend. With product expansion (single-stock futures for Tesla and SpaceX) and a policy backdrop that should sustain trading volumes, CME is a quality growth name to own on a pullback. This trade plan uses an entry near the cu…

Westamerica Bancorporation Declares Quarterly Cash Dividend

Westamerica Bancorporation Declares Quarterly Cash Dividend

Westamerica Bancorporation announced a quarterly cash dividend of $0.48 per share payable on August 14, 2026, underscoring its reliable earnings and conservative risk profile. The company reported net income of $27.4 million for Q2 2026, or $1.17 diluted earnings per share. Westamerica Bancorporation operates banking and trust offices in Northern a…

U.S. Bonds Trail European and Asian Peers Over One and Five Years

U.S. Bonds Trail European and Asian Peers Over One and Five Years

Over the past year U.S. bond returns have been modest while their five-year performance is negative. International equity and developed-market ETFs, particularly those tied to Europe and Japan, have outpaced U.S. bond benchmarks, a divergence driven by higher U.S. rates, relatively firmer U.S. inflation, and differing central bank stances.

UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026

UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026

Omada Health, a Nasdaq-listed virtual healthcare provider focused on chronic condition management, announced it will release its Q2 2026 financial results on August 6, 2026, followed by a conference call to discuss the results. The company highlights its virtual-first care model leveraging human teams, connected devices, and AI to manage conditions…

Truist Lowers Norwegian Cruise Line Rating as Promotional Pressure Mounts

Truist Lowers Norwegian Cruise Line Rating as Promotional Pressure Mounts

Truist Securities cut its rating on Norwegian Cruise Line Holdings to Hold from Buy, noting the stock's proximity to the firm's $20 price target and increased promotional activity across the mass-market cruise segment. The bank's July demand and price survey, along with discussions with senior industry executives and forward booking and pricing dat…